WO2005011593A3 - Liaison amelioree du pantoprazole et de la pompe a acide - Google Patents
Liaison amelioree du pantoprazole et de la pompe a acide Download PDFInfo
- Publication number
- WO2005011593A3 WO2005011593A3 PCT/US2004/024678 US2004024678W WO2005011593A3 WO 2005011593 A3 WO2005011593 A3 WO 2005011593A3 US 2004024678 W US2004024678 W US 2004024678W WO 2005011593 A3 WO2005011593 A3 WO 2005011593A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pantoprazole
- improved binding
- acid pump
- acid
- pump
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49127303P | 2003-07-31 | 2003-07-31 | |
US60/491,273 | 2003-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005011593A2 WO2005011593A2 (fr) | 2005-02-10 |
WO2005011593A3 true WO2005011593A3 (fr) | 2005-09-01 |
Family
ID=34115485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/024678 WO2005011593A2 (fr) | 2003-07-31 | 2004-07-30 | Liaison amelioree du pantoprazole et de la pompe a acide |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005011593A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102786483B (zh) * | 2011-05-19 | 2016-03-30 | 复旦大学 | 4-(4-苯基哌嗪基)喹唑啉类衍生物的药用用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025028A1 (fr) * | 1993-04-27 | 1994-11-10 | Sepracor, Inc. | Procedes et compositions de traitement de troubles gastriques a l'aide de pantoprazole (+) optiquement pur |
-
2004
- 2004-07-30 WO PCT/US2004/024678 patent/WO2005011593A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025028A1 (fr) * | 1993-04-27 | 1994-11-10 | Sepracor, Inc. | Procedes et compositions de traitement de troubles gastriques a l'aide de pantoprazole (+) optiquement pur |
Non-Patent Citations (2)
Title |
---|
CURRENT OPINION IN GASTEROENTEROLOGY, vol. 19, no. 6, 2003, pages 519 - 525 * |
DATABASE BIOBASE [online] SCHUBERT M.K. ET AL: "Gastric Secretion", accession no. STN Database accession no. (2003267791) * |
Also Published As
Publication number | Publication date |
---|---|
WO2005011593A2 (fr) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003059251A3 (fr) | Composes de ciblage d'anticorps | |
WO2006007207A3 (fr) | Procedes et dispositifs pour la determination de sequence d'acides nucleiques | |
WO2007024705A3 (fr) | Procede de traitement de la depression au moyen d'un anticorps anti-tnf-alpha | |
WO2006023651A3 (fr) | Traitement prolonge de la sclerose en plaques | |
WO2006037811A3 (fr) | Composes d'exendin-4 a action prolongee | |
WO2009052431A3 (fr) | Agents de liaison au cd19 et utilisations de ceux-ci | |
WO2006034035A3 (fr) | Traitement de l'ischemie | |
WO2005075412A3 (fr) | Composes cycloaliphatiques a base de norbonane contenant des groupes nitriles | |
WO2006039250A3 (fr) | Sels de compose heterocyclique se liant aux chimiokines et procedes d'utilisation correspondants | |
ZA200208489B (en) | Salt-sensitive, water-dispersible polymer composition. | |
WO2003093472A3 (fr) | Acides nucleiques liant le cgrp | |
WO2006029398A8 (fr) | Tout-trans-retinol:tout-trans-13,14-dihydroretinol saturase et procedes d'utilisation de cette enzyme | |
WO2004032908A3 (fr) | Methode d'inhibition de l'angiogenese | |
WO2004075021A3 (fr) | Procedes de modelisation moleculaire | |
WO2006014877A3 (fr) | Inhibiteurs de canaux potassiques | |
WO2003066097A3 (fr) | Nouvelle cible pour inhiber l'angiogenese | |
WO2006023586A3 (fr) | Composes de guanylhydrazone, compositions de guanylhydrazone, ainsi que leurs methodes de fabrication | |
WO2004098599A3 (fr) | Agents pour le traitement de troubles du bas-ventre | |
WO2004013274A3 (fr) | Acides nucleiques a liaison de ghreline | |
IL173654A0 (en) | 1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof | |
WO2006004613A3 (fr) | Sels de guanylhydrazone, compositions a base de ceux-ci, procedes et production et d'utilisation de ceux-ci | |
WO2004092481A3 (fr) | Procede de traitement de surfaces de papier | |
WO2005034840A3 (fr) | Identification d'inhibiteurs de kinase | |
WO2005011593A3 (fr) | Liaison amelioree du pantoprazole et de la pompe a acide | |
WO2008028032A3 (fr) | Hydantoïnes substituées, thérapeutiques, et composés associés |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |